日本調剤(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 小売業 | 3341/E05422 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2017/08/10 | 日証協 | 606,282株 | -1.29% | 32,500株 | -61.13% | 672,488株 | +0.75% | 37,200株 | +19.23% |
2017/08/04 | 日証協 | 614,224株 | -8.74% | 83,602株 | -78.19% | 667,488株 | -4.94% | 31,200株 | +23.79% |
2017/07/28 | 日証協 | 673,052株 | +13.73% | 383,378株 | +1131.26% | 702,168株 | +7.14% | 25,203株 | -35.54% |
2017/07/21 | 日証協 | 591,787株 | +0.89% | 31,137株 | +196.88% | 655,350株 | +1.79% | 39,100株 | +218.02% |
2017/07/14 | 日証協 | 586,550株 | +0.23% | 10,488株 | -70.5% | 643,800株 | +1.31% | 12,295株 | -48.64% |
2017/07/07 | 日証協 | 585,203株 | +3.43% | 35,549株 | +54.56% | 635,489株 | +2.52% | 23,939株 | +38.27% |
2017/06/30 | 日証協 | 565,780株 | -0.3% | 23,000株 | +248.48% | 619,851株 | +0.46% | 17,313株 | +61.8% |
2017/06/23 | 日証協 | 567,498株 | -3.06% | 6,600株 | -75.94% | 617,038株 | -0.02% | 10,700株 | -58.58% |
2017/06/16 | 日証協 | 585,398株 | +0.16% | 27,433株 | -25.45% | 617,138株 | +0.67% | 25,833株 | +84.52% |
2017/06/09 | 日証協 | 584,436株 | +5.8% | 36,800株 | -20.65% | 613,018株 | +4.39% | 14,000株 | -39.13% |
2017/06/02 | 日証協 | 552,398株 | -5.32% | 46,374株 | -82.95% | 587,218株 | -1.38% | 23,000株 | +995.24% |
2017/05/26 | 日証協 | 583,456株 | -1.84% | 271,942株 | +2531.78% | 595,428株 | -0.47% | 2,100株 | -57.14% |
2017/05/19 | 日証協 | 594,403株 | +2.53% | 10,333株 | -83.88% | 598,228株 | -0.18% | 4,900株 | -89.98% |
2017/05/12 | 日証協 | 579,736株 | +0.8% | 64,107株 | +933.98% | 599,328株 | -2.35% | 48,900株 | +6885.71% |
2017/05/02 | 日証協 | 575,156株 | -1.41% | 6,200株 | -61.01% | 613,758株 | -1.54% | 700株 | -99.79% |
2017/04/28 | 日証協 | 583,386株 | -1.2% | 15,900株 | +4.61% | 623,368株 | -1.5% | 340,079株 | +8154.34% |
2017/04/21 | 日証協 | 590,486株 | +1.26% | 15,200株 | +39.45% | 632,868株 | -0.14% | 4,120株 | -99.41% |
2017/04/14 | 日証協 | 583,154株 | +1.79% | 10,900株 | -73.78% | 633,756株 | -0.72% | 694,858株 | +91.75% |
2017/04/07 | 日証協 | 572,904株 | -3.84% | 41,575株 | -85.11% | 638,381株 | -0.93% | 362,374株 | -49.51% |
※株式分割は考慮していませんのでご注意ください。
Page Top